first large study of glp-1 receptor agonists during pregnancy Agonist Use Across Preconception, Pregnancy, and the Postpartum Periods | Pediatric Drugs How safe are GLP-1R agonists

The terminal ileum is the most common site (~70% of cases)

The significant release of growth hormone itself is associated with both the suppression of somatostatin and the stimulation of the release of growth hormone GH from the anterior pituitary gland, as is the case with GHRP-6

Manning CS et al (2019) Quantitative single-cell live imaging links HES5 dynamics with cell-state and fate in murine neurogenesis

This review asks a deliberately narrow, evidence-first question: does the existing preclinical literature actually support a safety conclusion for BPC-157 and TB-500 Does Experimental Literature Suggest Distinct Neuroregenerative Functions for TB-500 and BPC-157

Minimal erythemal dose (MED)

The 12-week mark aligns with what clinical GHK-Cu skin trials use as their primary endpoint, and the published results from those trials reflect what researchers running systematic protocols report: clear, documented improvement in skin architecture